These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection? Porter BW; Venkatappa TK Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis of tuberculosis and drug resistance: what can new tools bring us? Drobniewski F; Nikolayevskyy V; Balabanova Y; Bang D; Papaventsis D Int J Tuberc Lung Dis; 2012 Jul; 16(7):860-70. PubMed ID: 22687497 [TBL] [Abstract][Full Text] [Related]
8. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy. Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066 [TBL] [Abstract][Full Text] [Related]
9. [Tuberculosis in 2015: From diagnosis to the detection of multiresistant cases]. Hervé C; Bergot E; Veziris N; Blanc FX Rev Mal Respir; 2015 Oct; 32(8):784-90. PubMed ID: 26169235 [TBL] [Abstract][Full Text] [Related]
10. [Clinical application of testing methods on acid-fast bacteria]. Ichiyama S; Suzuki K Kekkaku; 2005 Feb; 80(2):95-111. PubMed ID: 15920982 [TBL] [Abstract][Full Text] [Related]
12. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area. Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158 [TBL] [Abstract][Full Text] [Related]
13. Interferon-γ release assays for diagnosis of tuberculosis infection and disease in children. Starke JR; Pediatrics; 2014 Dec; 134(6):e1763-73. PubMed ID: 25422024 [TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis. Davidow AL Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015 [TBL] [Abstract][Full Text] [Related]
15. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Pai M; Kalantri S; Dheda K Expert Rev Mol Diagn; 2006 May; 6(3):423-32. PubMed ID: 16706744 [TBL] [Abstract][Full Text] [Related]
16. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study. Li Q; Ou XC; Pang Y; Xia H; Huang HR; Zhao B; Wang SF; Zhao YL Tuberculosis (Edinb); 2017 Jul; 105():9-12. PubMed ID: 28610793 [TBL] [Abstract][Full Text] [Related]
17. [The present and future prospects in rapid molecular diagnosis of tuberculosis and MDR-TB (First Part)]. Tănăsescu M; Didilescu C; Marica C Pneumologia; 2013; 62(3):134-8. PubMed ID: 24273995 [TBL] [Abstract][Full Text] [Related]
18. Position statement on interferon-γ release assays for the detection of latent tuberculosis infection. Bastian I; Coulter C; Commun Dis Intell Q Rep; 2017 Dec; 41(4):E322-E336. PubMed ID: 29864386 [TBL] [Abstract][Full Text] [Related]
19. Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India. Georghiou SB; Ajbani K; Rodrigues C; Rodwell TC Int J Tuberc Lung Dis; 2016 Feb; 20(2):160-5. PubMed ID: 26792466 [TBL] [Abstract][Full Text] [Related]
20. Detection of multidrug-resistant tuberculosis using MGIT™(TM) and MAS-PCR in Tripura, India. Majumdar T; Bhattacharya S; Barman D; Bhoumik P; Bir R Int J Tuberc Lung Dis; 2016 Feb; 20(2):166-9. PubMed ID: 26792467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]